Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs—reducing global inequity
Publication date
2024-10
Authors
Zar, Heather J.
Piccolis, Manuele
Terstappen, Jonne
Mazur, Natalie I.
Gaayeb, Lobna
Morin, Sébastien
Bont, Louis J
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
Keywords
General Medicine
Citation
Zar, H J, Piccolis, M, Terstappen, J, Mazur, N I, Gaayeb, L, Morin, S & Bont, L 2024, 'Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs—reducing global inequity', The Lancet Global Health, vol. 12, no. 10, pp. e1582-e1583. https://doi.org/10.1016/S2214-109X(24)00258-4